高级搜索
不同临床分期宫颈癌组织蛋白质组学的比较[J]. 肿瘤防治研究, 2010, 37(12): 1404-1408. DOI: 10.3971/j.issn.1000-8578.2010.12.019
引用本文: 不同临床分期宫颈癌组织蛋白质组学的比较[J]. 肿瘤防治研究, 2010, 37(12): 1404-1408. DOI: 10.3971/j.issn.1000-8578.2010.12.019
Comparative Proteomic of Cervical Carcinoma Tissues at Differential Clinical Stages[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1404-1408. DOI: 10.3971/j.issn.1000-8578.2010.12.019
Citation: Comparative Proteomic of Cervical Carcinoma Tissues at Differential Clinical Stages[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1404-1408. DOI: 10.3971/j.issn.1000-8578.2010.12.019

不同临床分期宫颈癌组织蛋白质组学的比较

Comparative Proteomic of Cervical Carcinoma Tissues at Differential Clinical Stages

  • 摘要: 目的 通过比较不同临床分期宫颈癌组织的差异表达蛋白,以发现与宫颈癌临床分期相关蛋白,为临床预后和复发的预测提供新指标。方法 收集不同临床分期宫颈癌组织,分为早期宫颈癌组和中晚期宫颈癌组,提取组织总蛋白进行二维凝胶电泳,选择部分差异表达蛋白进行MALDI-TOF质谱分析和生物信息学分析,Western blot和免疫组织化学技术检测部分差异表达蛋白HSP70和Galectin-7的表达情况。结果 建立了早期宫颈癌组和中晚期宫颈癌组的二维凝胶电泳图谱,其中两组的平均蛋白质点数分别为(1 098±23)、(1 142±21),通过进行质谱分析和生物信息学查询,鉴定了显著差异表达的12个蛋白点,在早期组上调的4个,包括Hemoglobin subunit beta Hb、caspase-14、Galectin-7 、CK19;中晚期组上调的8个,包括Lamin-B1、Flavin reductase、Glutamate dehydrogenase 1、 Retinal dehydrogenase 1、NMP238 、HSP70、Calmodulin-like 5、S100A9。Western blot和免疫组织化学检测结果均显示HSP70在中晚期组中的表达高于早期组,Galectin-7在早期组中的表达高于中晚期组。结论 不同临床分期的宫颈癌中存在着差异表达蛋白,这些蛋白可能是宫颈癌诊断和预后的生物标志物。

     

    Abstract: Abstract: Objective To study the effect of rotary magnetic field (RMF) combining 5-Fu on the cycle and apoptosis of mouse cell line SP2/0 in vitro. Methods SP2/0 cells were randomly divided into four groups: control group (N), 5-Fu group (C), magnetic group (M) and magnetic combining 5-Fu group (M+C).The M and M+C groups were treated with a RMF for two hours once a day.On day 4, the C and M+C groups were treated with 5-Fu 20 μg/ml.On day 5, cell cycle and apoptosis were measured by the flow cytometric (FCM). Results The S phase proportion of the M group and the G1 phase proportion of the C group were higher than that of the other three groups(P<0.05).The S phase proportion of the M+C group decreased and lower than that of the M group,but was still higher than that of the N and C groups(P<0.05).There was no significant difference in apoptosis rates between the N and M groups(P>0.05).The apoptosis rates of the C and M+C groups were remarkedly higher than those of the N and M groups and the M+C group had the highest apoptosis rate. Conclusion The RMF can't induce the apoptosis.But it can enhance the cytotoxicity of 5-Fu and promote the cell apoptosis.The mechanism of the apoptosis may be related to SP2/0 cell line arrested at S phase.Objective Cervical carcinoma clinical stages associated proteins would be found by comparing differential expressed proteins from differential clinical stage cervical carcinoma tissues. Methods Total protein from cervical carcinoma tissues was extracted; differential proteome profiles were established and analysized by means of immobilized pH gradient-based two-dimensional polyacrylamide gel electrophoresis(2D-PAGE) and matrix-assisted laser desorption/ionization time of flight mass spectrometry(MALDI-TOF-MS).HSP70 and Galectin-7 expression were assayed by Western Blot and immunohistochemical technique. Results Well-resolved reproducible 2-DE profiles of human cervical carcinoma tissues were obtained.Average protein dots were(1 098±23),(1 142±21) at early-stage and medium-advanced stage respectively; By analysis with mass spectrometry and bioinformatics, 12 of them were well characterized.4 proteins were over-expressed in early-stage group, including Hemoglobin subunit beta HB,caspase-14,Galectin-7,CK19; 8 protein were over-expressed in medium-advanced stage, including Lamin-B1,Flavin reductase、Glutamate dehydrogenase 1,Retinal dehydrogenase 1,NMP238,HSP70,Calmodulin-like 5,S100A9.HSP70 expressed higher at medium-advanced stage group than at early-stage group and Galectin-7 expressed higher at early-stage group than at medium-advanced group. Conclusion Differential expressed proteins exist in clinical stage of cervical carcinoma, which would be biomarkers for diagnosis and prediction of prognosis.

     

/

返回文章
返回